Germany Internet of Things in Healthcare Market

Germany Internet of Things in Healthcare Market Research Report: Size, Share, Trend Analysis By Applications (Patient Monitoring, Medication Management, Telemedicine, Clinical Operations, Asset Management), By Component (Devices, Software, Services), By End Use (Hospitals, Diagnostics Centers, Home Care) and By Technology (Wearable Technology, Remote Patient Monitoring, Smart Medical Devices) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period
2025 - 2035
CAGR
12.27%
2024 Market Size
$ 5.6 Billion
2035 Market Size
$ 20 Billion
Medical Device ● Updated August 2026 Report ID: MRFR/MED/49827-HCR | Pages: 200 | Author: Vikita Thakur, Garvit Vyas
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Application (USD Billion)
      1. 4.1.1 Patient Monitoring
      2. 4.1.2 Medication Management
      3. 4.1.3 Telemedicine
      4. 4.1.4 Clinical Operations
      5. 4.1.5 Asset Management
    2. 4.2 Pharmaceutical, BY Component (USD Billion)
      1. 4.2.1 Devices
      2. 4.2.2 Software
      3. 4.2.3 Services
    3. 4.3 Pharmaceutical, BY End-Use (USD Billion)
      1. 4.3.1 Hospitals
      2. 4.3.2 Diagnostics Centers
      3. 4.3.3 Home Care
    4. 4.4 Pharmaceutical, BY Technology (USD Billion)
      1. 4.4.1 Wearable Technology
      2. 4.4.2 Remote Patient Monitoring
      3. 4.4.3 Smart Medical Devices
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Philips (NL)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 GE Healthcare (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Siemens Healthineers (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Medtronic (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 IBM (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Cisco Systems (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Honeywell (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Oracle (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GERMANY MARKET ANALYSIS BY APPLICATION
    3. 6.3 GERMANY MARKET ANALYSIS BY COMPONENT
    4. 6.4 GERMANY MARKET ANALYSIS BY END-USE
    5. 6.5 GERMANY MARKET ANALYSIS BY TECHNOLOGY
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Billion)
    14. 6.14 PHARMACEUTICAL, BY COMPONENT, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY COMPONENT, 2024 TO 2035 (USD Billion)
    16. 6.16 PHARMACEUTICAL, BY END-USE, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY END-USE, 2024 TO 2035 (USD Billion)
    18. 6.18 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
      2. 7.2.2 BY COMPONENT, 2025-2035 (USD Billion)
      3. 7.2.3 BY END-USE, 2025-2035 (USD Billion)
      4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1
Share::
Request Free Sample

Germany Internet of Things in Healthcare Market Segmentation

Germany Internet of Things in Healthcare Market By Application (USD Billion, 2025-2035)

  • Patient Monitoring
  • Medication Management
  • Telemedicine
  • Clinical Operations
  • Asset Management

Germany Internet of Things in Healthcare Market By Component (USD Billion, 2025-2035)

  • Devices
  • Software
  • Services

Germany Internet of Things in Healthcare Market By End-Use (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostics Centers
  • Home Care

Germany Internet of Things in Healthcare Market By Technology (USD Billion, 2025-2035)

  • Wearable Technology
  • Remote Patient Monitoring
  • Smart Germany Internet of Things in Healthcare Markets
Share::
Request Free Sample
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.